Table Of Contents
1. Introduction
1.1 Market Definition & Scope
1.2 Research Assumptions & Abbreviations
1.3 Research Methodology
2. Executive Summary
2.1 Market Snapshot
2.2 Market Absolute $ Opportunity Assessment & Y-o-Y Analysis, 2021–2032
2.3 Market Size & Forecast, By Segmentation, 2021–2032
2.3.1 Market Size By Therapeutic Area
2.3.2 Market Size By Application
2.4 Market Share & Bps Analysis By Region, 2024
2.5 Industry Growth Scenarios – Conservative, Likely & Optimistic
2.6 Industry CxO’s Perspective
3. Market Overview
3.1 Market Dynamics
3.1.1 Drivers
3.1.2 Restraints
3.1.3 Opportunities
3.1.4 Key Market Trends
3.2 Industry PESTLE Analysis
3.3 Key Industry Forces (Porter’s) Impacting Market Growth
3.4 Industry Supply Chain Analysis
3.4.1 Raw Material Suppliers
3.4.2 Manufacturers
3.4.3 Distributors/Suppliers
3.4.4 Customers/End-Users
3.5 Industry Life Cycle Assessment
3.6 Parent Market Overview
3.7 Market Risk Assessment
4. Statistical Insights & Trends Reporting
4.1 Pricing & Cost Analysis
4.1.1 Average Cost Savings Achieved Using AI vs. Traditional Drug Discovery
4.1.2 Cost per AI-Driven Molecule Screening / Simulation
4.1.3 Regional Variations in AI Platform Licensing & Subscription Fees
4.1.4 Cost Comparison: In-House AI vs. Outsourced AI Drug Discovery Services
4.1.5 Emerging Pricing Models
4.2 R&D & Pipeline Metrics
4.2.1 % of Drug Discovery Programs Using AI Tools
4.2.2 Average Reduction in Lead Identification Time Using AI (Weeks / Months)
4.2.3 Number of Molecules Screened per Year Using AI Platforms
4.2.4 Clinical Trial Success Rate Improvement (%) with AI-Driven Target Identification
4.2.5 AI Adoption by Therapeutic Area (Oncology, Neurology, Infectious Diseases)
4.3 Technology & Innovation Metrics
4.3.1 % Adoption of Machine Learning, Deep Learning, and NLP in Drug Discovery
4.3.2 Integration Rate of AI Platforms with LIMS, EHR, and Bioinformatics Databases
4.3.3 R&D Investment Trends in AI Drug Discovery Solutions
4.3.4 Patent Filing Trends in AI Algorithms, Molecular Modeling, and Predictive Analytics
4.3.5 Emerging Platform Adoption Rate in Key Pharmaceutical Markets
4.4 Efficiency & Performance Metrics
4.4.1 Reduction in Time-to-Market for Drug Candidates (%)
4.4.2 Increase in Predictive Accuracy for Target Selection (%)
4.4.3 % Reduction in Preclinical Failure Rates
4.4.4 Cost-per-Lead Reduction Achieved via AI-Driven Screening
4.4.5 Average Number of Compounds Optimized per AI Cycle
4.5 Regulatory & Compliance Metrics
4.5.1 % AI Platforms Compliant with FDA, EMA, and PMDA Guidelines
4.5.2 Regional Regulatory Timelines for AI-Driven Drug Discovery Validation
4.5.3 Data Privacy Compliance (HIPAA, GDPR) for Patient & Clinical Data Usage
4.5.4 Post-Approval Validation Metrics for AI-Discovered Molecules
4.5.5 Guidelines for Documentation, Traceability, and AI Model Audits
5. Artificial Intelligence in Drug Discovery Market Segmental Analysis & Forecast, By Therapeutic Area, 2021 – 2032, Value (Usd Billion)
5.1 Introduction
5.2 Oncology
5.2.1 Key Trends
5.2.2 Market Size & Forecast, 2021 – 2032
5.3 Neurodegenerative Diseases
5.3.1 Key Trends
5.3.2 Market Size & Forecast, 2021 – 2032
5.4 Cardiovascular Disease
5.4.1 Key Trends
5.4.2 Market Size & Forecast, 2021 – 2032
5.5 Metabolic Diseases
5.5.1 Key Trends
5.5.2 Market Size & Forecast, 2021 – 2032
5.6 Infectious Disease
5.6.1 Key Trends
5.6.2 Market Size & Forecast, 2021 – 2032
5.7 Others
5.7.1 Key Trends
5.7.2 Market Size & Forecast, 2021 – 2032
6. Artificial Intelligence in Drug Discovery Market Segmental Analysis & Forecast, By Application, 2021 – 2032, Value (Usd Billion)
6.1 Introduction
6.2 Drug optimization and repurposing
6.2.1 Key Trends
6.2.2 Market Size & Forecast, 2021 – 2032
6.3 Preclinical testing
6.3.1 Key Trends
6.3.2 Market Size & Forecast, 2021 – 2032
6.4 Others
6.4.1 Key Trends
6.4.2 Market Size & Forecast, 2021 – 2032
7. Artificial Intelligence in Drug Discovery Market Segmental Analysis & Forecast By Region, 2021 – 2025, Value (Usd Billion)
7.1 Introduction
7.2 North America
7.2.1 Key Trends
7.2.2 Artificial Intelligence in Drug Discovery Market Size & Forecast, By Therapeutic Area, 2021 – 2032
7.2.3 Artificial Intelligence in Drug Discovery Market Size & Forecast, By Application, 2021 – 2032
7.2.4 Artificial Intelligence in Drug Discovery Market Size & Forecast, By Country, 2021 – 2032
7.2.4.1 USA
7.2.4.1.1 Artificial Intelligence in Drug Discovery Market Size & Forecast, By Therapeutic Area, 2021 – 2032
7.2.4.1.2 Artificial Intelligence in Drug Discovery Market Size & Forecast, By Application, 2021 – 2032
7.2.4.2 Canada
7.2.4.2.1 Artificial Intelligence in Drug Discovery Market Size & Forecast, By Therapeutic Area, 2021 – 2032
7.2.4.2.2 Artificial Intelligence in Drug Discovery Market Size & Forecast, By Application, 2021 – 2032
7.3 Europe
7.3.1 Key Trends
7.3.2 Artificial Intelligence in Drug Discovery Market Size & Forecast, By Therapeutic Area, 2021 – 2032
7.3.3 Artificial Intelligence in Drug Discovery Market Size & Forecast, By Application, 2021 – 2032
7.3.4 Artificial Intelligence in Drug Discovery Market Size & Forecast, By Country, 2021 – 2032
7.3.4.1 Germany
7.3.4.1.1 Artificial Intelligence in Drug Discovery Market Size & Forecast, By Therapeutic Area, 2021 – 2032
7.3.4.1.2 Artificial Intelligence in Drug Discovery Market Size & Forecast, By Application, 2021 – 2032
7.3.4.2 UK
7.3.4.2.1 Artificial Intelligence in Drug Discovery Market Size & Forecast, By Therapeutic Area, 2021 – 2032
7.3.4.2.2 Artificial Intelligence in Drug Discovery Market Size & Forecast, By Application, 2021 – 2032
7.3.4.3 France
7.3.4.3.1 Artificial Intelligence in Drug Discovery Market Size & Forecast, By Therapeutic Area, 2021 – 2032
7.3.4.3.2 Artificial Intelligence in Drug Discovery Market Size & Forecast, By Application, 2021 – 2032
7.3.4.4 Italy
7.3.4.4.1 Artificial Intelligence in Drug Discovery Market Size & Forecast, By Therapeutic Area, 2021 – 2032
7.3.4.4.2 Artificial Intelligence in Drug Discovery Market Size & Forecast, By Application, 2021 – 2032
7.3.4.5 Spain
7.3.4.5.1 Artificial Intelligence in Drug Discovery Market Size & Forecast, By Therapeutic Area, 2021 – 2032
7.3.4.5.2 Artificial Intelligence in Drug Discovery Market Size & Forecast, By Application, 2021 – 2032
7.3.4.6 Russia
7.3.4.6.1 Artificial Intelligence in Drug Discovery Market Size & Forecast, By Therapeutic Area, 2021 – 2032
7.3.4.6.2 Artificial Intelligence in Drug Discovery Market Size & Forecast, By Application, 2021 – 2032
7.3.4.7 Poland
7.3.4.7.1 Artificial Intelligence in Drug Discovery Market Size & Forecast, By Therapeutic Area, 2021 – 2032
7.3.4.7.2 Artificial Intelligence in Drug Discovery Market Size & Forecast, By Application, 2021 – 2032
7.3.4.8 Rest of Europe
7.3.4.8.1 Artificial Intelligence in Drug Discovery Market Size & Forecast, By Therapeutic Area, 2021 – 2032
7.3.4.8.2 Artificial Intelligence in Drug Discovery Market Size & Forecast, By Application, 2021 – 2032
7.4 Asia-Pacific
7.4.1 Key Trends
7.4.2 Artificial Intelligence in Drug Discovery Market Size & Forecast, By Therapeutic Area, 2021 – 2032
7.4.3 Artificial Intelligence in Drug Discovery Market Size & Forecast, By Application, 2021 – 2032
7.4.4 Artificial Intelligence in Drug Discovery Market Size & Forecast, By Country, 2021 – 2032
7.4.4.1 China
7.4.4.1.1 Artificial Intelligence in Drug Discovery Market Size & Forecast, By Therapeutic Area, 2021 – 2032
7.4.4.1.2 Artificial Intelligence in Drug Discovery Market Size & Forecast, By Application, 2021 – 2032
7.4.4.2 India
7.4.4.2.1 Artificial Intelligence in Drug Discovery Market Size & Forecast, By Therapeutic Area, 2021 – 2032
7.4.4.2.2 Artificial Intelligence in Drug Discovery Market Size & Forecast, By Application, 2021 – 2032
7.4.4.3 Japan
7.4.4.3.1 Artificial Intelligence in Drug Discovery Market Size & Forecast, By Therapeutic Area, 2021 – 2032
7.4.4.3.2 Artificial Intelligence in Drug Discovery Market Size & Forecast, By Application, 2021 – 2032
7.4.4.4 South Korea
7.4.4.4.1 Artificial Intelligence in Drug Discovery Market Size & Forecast, By Therapeutic Area, 2021 – 2032
7.4.4.4.2 Artificial Intelligence in Drug Discovery Market Size & Forecast, By Application, 2021 – 2032
7.4.4.5 Australia
7.4.4.5.1 Artificial Intelligence in Drug Discovery Market Size & Forecast, By Therapeutic Area, 2021 – 2032
7.4.4.5.2 Artificial Intelligence in Drug Discovery Market Size & Forecast, By Application, 2021 – 2032
7.4.4.6 ASEAN Countries
7.4.4.6.1 Artificial Intelligence in Drug Discovery Market Size & Forecast, By Therapeutic Area, 2021 – 2032
7.4.4.6.2 Artificial Intelligence in Drug Discovery Market Size & Forecast, By Application, 2021 – 2032
7.4.4.7 Rest of Asia-Pacific
7.4.4.7.1 Artificial Intelligence in Drug Discovery Market Size & Forecast, By Therapeutic Area, 2021 – 2032
7.4.4.7.2 Artificial Intelligence in Drug Discovery Market Size & Forecast, By Application, 2021 – 2032
7.5 Latin America
7.5.1 Key Trends
7.5.2 Artificial Intelligence in Drug Discovery Market Size & Forecast, By Therapeutic Area, 2021 – 2032
7.5.3 Artificial Intelligence in Drug Discovery Market Size & Forecast, By Application, 2021 – 2032
7.5.4 Artificial Intelligence in Drug Discovery Market Size & Forecast, By Country, 2021 – 2032
7.5.4.1 Brazil
7.5.4.1.1 Artificial Intelligence in Drug Discovery Market Size & Forecast, By Therapeutic Area, 2021 – 2032
7.5.4.1.2 Artificial Intelligence in Drug Discovery Market Size & Forecast, By Application, 2021 – 2032
7.5.4.2 Argentina
7.5.4.2.1 Artificial Intelligence in Drug Discovery Market Size & Forecast, By Therapeutic Area, 2021 – 2032
7.5.4.2.2 Artificial Intelligence in Drug Discovery Market Size & Forecast, By Application, 2021 – 2032
7.5.4.3 Mexico
7.5.4.3.1 Artificial Intelligence in Drug Discovery Market Size & Forecast, By Therapeutic Area, 2021 – 2032
7.5.4.3.2 Artificial Intelligence in Drug Discovery Market Size & Forecast, By Application, 2021 – 2032
7.5.4.4 Colombia
7.5.4.4.1 Artificial Intelligence in Drug Discovery Market Size & Forecast, By Therapeutic Area, 2021 – 2032
7.5.4.4.2 Artificial Intelligence in Drug Discovery Market Size & Forecast, By Application, 2021 – 2032
7.5.4.5 Rest of Latin America
7.5.4.5.1 Artificial Intelligence in Drug Discovery Market Size & Forecast, By Therapeutic Area, 2021 – 2032
7.5.4.5.2 Artificial Intelligence in Drug Discovery Market Size & Forecast, By Application, 2021 – 2032
7.6 Middle East & Africa
7.6.1 Key Trends
7.6.2 Artificial Intelligence in Drug Discovery Market Size & Forecast, By Therapeutic Area, 2021 – 2032
7.6.3 Artificial Intelligence in Drug Discovery Market Size & Forecast, By Application, 2021 – 2032
7.6.4 Artificial Intelligence in Drug Discovery Market Size & Forecast, By Country, 2021 – 2032
7.6.4.1 UAE
7.6.4.1.1 Artificial Intelligence in Drug Discovery Market Size & Forecast, By Therapeutic Area, 2021 – 2032
7.6.4.1.2 Artificial Intelligence in Drug Discovery Market Size & Forecast, By Application, 2021 – 2032
7.6.4.2 Saudi Arabia
7.6.4.2.1 Artificial Intelligence in Drug Discovery Market Size & Forecast, By Therapeutic Area, 2021 – 2032
7.6.4.2.2 Artificial Intelligence in Drug Discovery Market Size & Forecast, By Application, 2021 – 2032
7.6.4.3 Qatar
7.6.4.3.1 Artificial Intelligence in Drug Discovery Market Size & Forecast, By Therapeutic Area, 2021 – 2032
7.6.4.3.2 Artificial Intelligence in Drug Discovery Market Size & Forecast, By Application, 2021 – 2032
7.6.4.4 Egypt
7.6.4.4.1 Artificial Intelligence in Drug Discovery Market Size & Forecast, By Therapeutic Area, 2021 – 2032
7.6.4.4.2 Artificial Intelligence in Drug Discovery Market Size & Forecast, By Application, 2021 – 2032
7.6.4.5 South Africa
7.6.4.5.1 Artificial Intelligence in Drug Discovery Market Size & Forecast, By Therapeutic Area, 2021 – 2032
7.6.4.5.2 Artificial Intelligence in Drug Discovery Market Size & Forecast, By Application, 2021 – 2032
7.6.4.6 Rest of Middle East & Africa
7.6.4.6.1 Artificial Intelligence in Drug Discovery Market Size & Forecast, By Therapeutic Area, 2021 – 2032
7.6.4.6.2 Artificial Intelligence in Drug Discovery Market Size & Forecast, By Application, 2021 – 2032
8. Competitive Landscape
8.1 Key Players' Positioning
8.2 Competitive Developments
8.2.1 Key Strategies Adopted (%), By Key Players, 2024
8.2.2 Year-Wise Strategies & Development, 2021 – 2025
8.2.3 Number Of Strategies Adopted By Key Players, 2024
8.3 Market Share Analysis, 2024
8.4 Product/Service & Application Benchmarking
8.4.1 Product/Service Specifications & Features By Key Players
8.4.2 Product/Service Heatmap By Key Players
8.4.3 Application Heatmap By Key Players
8.5 Industry Start-Up & Innovation Landscape
8.6 Key Company Profiles
8.6.1 IBM
8.6.1.1 Company Overview & Snapshot
8.6.1.2 Product/Service Portfolio
8.6.1.3 Key Company Financials
8.6.1.4 SWOT Analysis
8.6.2 Exscientia
8.6.2.1 Company Overview & Snapshot
8.6.2.2 Product/Service Portfolio
8.6.2.3 Key Company Financials
8.6.2.4 SWOT Analysis
8.6.3 Insilico Medicine
8.6.3.1 Company Overview & Snapshot
8.6.3.2 Product/Service Portfolio
8.6.3.3 Key Company Financials
8.6.3.4 SWOT Analysis
8.6.4 PandaOmics
8.6.4.1 Company Overview & Snapshot
8.6.4.2 Product/Service Portfolio
8.6.4.3 Key Company Financials
8.6.4.4 SWOT Analysis
8.6.5 ChemICo
8.6.5.1 Company Overview & Snapshot
8.6.5.2 Product/Service Portfolio
8.6.5.3 Key Company Financials
8.6.5.4 SWOT Analysis
8.6.6 GNS Healthcare
8.6.6.1 Company Overview & Snapshot
8.6.6.2 Product/Service Portfolio
8.6.6.3 Key Company Financials
8.6.6.4 SWOT Analysis
8.6.7 Google (DeepMind)
8.6.7.1 Company Overview & Snapshot
8.6.7.2 Product/Service Portfolio
8.6.7.3 Key Company Financials
8.6.7.4 SWOT Analysis
8.6.8 BenevolentAI
8.6.8.1 Company Overview & Snapshot
8.6.8.2 Product/Service Portfolio
8.6.8.3 Key Company Financials
8.6.8.4 SWOT Analysis
8.6.9 BioSymetrics, Inc.
8.6.9.1 Company Overview & Snapshot
8.6.9.2 Product/Service Portfolio
8.6.9.3 Key Company Financials
8.6.9.4 SWOT Analysis
8.6.10 Berg Health
8.6.10.1 Company Overview & Snapshot
8.6.10.2 Product/Service Portfolio
8.6.10.3 Key Company Financials
8.6.10.4 SWOT Analysis
8.6.11 Atomwise Inc.
8.6.11.1 Company Overview & Snapshot
8.6.11.2 Product/Service Portfolio
8.6.11.3 Key Company Financials
8.6.11.4 SWOT Analysis
8.6.12 Insitro
8.6.12.1 Company Overview & Snapshot
8.6.12.2 Product/Service Portfolio
8.6.12.3 Key Company Financials
8.6.12.4 SWOT Analysis
8.6.13 CYCLICA (Acquired by Recursion)
8.6.13.1 Company Overview & Snapshot
8.6.13.2 Product/Service Portfolio
8.6.13.3 Key Company Financials
8.6.13.4 SWOT Analysis
8.6.14 NVIDIA Corporation
8.6.14.1 Company Overview & Snapshot
8.6.14.2 Product/Service Portfolio
8.6.14.3 Key Company Financials
8.6.14.4 SWOT Analysis
8.6.15 Schrödinger, Inc.
8.6.15.1 Company Overview & Snapshot
8.6.15.2 Product/Service Portfolio
8.6.15.3 Key Company Financials
8.6.15.4 SWOT Analysis
8.6.16 Microsoft
8.6.16.1 Company Overview & Snapshot
8.6.16.2 Product/Service Portfolio
8.6.16.3 Key Company Financials
8.6.16.4 SWOT Analysis
8.6.17 Illumina, Inc.
8.6.17.1 Company Overview & Snapshot
8.6.17.2 Product/Service Portfolio
8.6.17.3 Key Company Financials
8.6.17.4 SWOT Analysis
8.6.18 Numedii, Inc.
8.6.18.1 Company Overview & Snapshot
8.6.18.2 Product/Service Portfolio
8.6.18.3 Key Company Financials
8.6.18.4 SWOT Analysis
8.6.19 Xtalpi Inc.
8.6.19.1 Company Overview & Snapshot
8.6.19.2 Product/Service Portfolio
8.6.19.3 Key Company Financials
8.6.19.4 SWOT Analysis
8.6.20 Iktos
8.6.20.1 Company Overview & Snapshot
8.6.20.2 Product/Service Portfolio
8.6.20.3 Key Company Financials
8.6.20.4 SWOT Analysis
9. Analyst Recommendations
9.1 SNS Insider Opportunity Map
9.2 Industry Low-Hanging Fruit Assessment
9.3 Market Entry & Growth Strategy
9.4 Analyst Viewpoint & Suggestions On Market Growth
10. Assumptions
11. Disclaimer
12. Appendix
12.1 List Of Tables
12.2 List Of Figures
